{
  "id": "5a6f77d7b750ff4455000051",
  "type": "yesno",
  "question": "Is autosomal dominant inheritanced form of Osteogenesis imperfecta caused by mutations in the genes associated with collagen production?",
  "ideal_answer": "Osteogenesis imperfecta (OI), also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones. The autosomal dominant form of the disease is cause by a mutation in the COL1A1 or COL1A2 genes which produce type I collagen.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27312322",
    "http://www.ncbi.nlm.nih.gov/pubmed/2992938",
    "http://www.ncbi.nlm.nih.gov/pubmed/27677223",
    "http://www.ncbi.nlm.nih.gov/pubmed/21567925",
    "http://www.ncbi.nlm.nih.gov/pubmed/22863195",
    "http://www.ncbi.nlm.nih.gov/pubmed/28116328",
    "http://www.ncbi.nlm.nih.gov/pubmed/18566967",
    "http://www.ncbi.nlm.nih.gov/pubmed/27510842",
    "http://www.ncbi.nlm.nih.gov/pubmed/21341209",
    "http://www.ncbi.nlm.nih.gov/pubmed/28820180",
    "http://www.ncbi.nlm.nih.gov/pubmed/2886666",
    "http://www.ncbi.nlm.nih.gov/pubmed/24928016",
    "http://www.ncbi.nlm.nih.gov/pubmed/29150909",
    "http://www.ncbi.nlm.nih.gov/pubmed/2037280",
    "http://www.ncbi.nlm.nih.gov/pubmed/8456806",
    "http://www.ncbi.nlm.nih.gov/pubmed/27762305",
    "http://www.ncbi.nlm.nih.gov/pubmed/21667357",
    "http://www.ncbi.nlm.nih.gov/pubmed/19533842",
    "http://www.ncbi.nlm.nih.gov/pubmed/25402547",
    "http://www.ncbi.nlm.nih.gov/pubmed/20839288",
    "http://www.ncbi.nlm.nih.gov/pubmed/12362985"
  ],
  "snippets": [
    {
      "text": "steogenesis imperfecta (OI) is a heterogeneous bone disorder characterized by recurrent fractures. Although most cases of OI have heterozygous mutations inCOL1A1orCOL1A2and show autosomal dominant inheritance,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116328",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) is a group of hereditary disorders characterized by decreased bone mass and increased fracture risk. The majority of OI cases have an autosomal dominant pattern of inheritance and are usually caused by mutations in genes encoding type I collagen",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27762305",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Osteogenesis imperfecta (OI) is a group of hereditary disorders characterized by low bone mass and recurrent fractures. Most OI cases follow an autosomal dominant pattern of inheritance and are attributed to mutations in genes encoding type I collagen (COL1A1/COL1A2). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27312322",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) is a genetic disorder characterised by low bone mineral density resulting in fractures. 85-90% of patients with OI carry a variant in the type 1 collagen genes, COL1A1 and COL1A2, which follows an autosomal dominant pattern of inheritance.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27677223",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) comprises a heterogeneous group of disorders that are characterized by susceptibility to bone fractures, and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Most patients have defects in type I collagen biosynthesis with autosomal-dominant inheritance, but many autosomal-recessive genes have been reported.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25402547",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To investigate mutation of COL1A1 gene and analyze the relationship between genotype and clinical phenotype in a family with osteogenesis imperfecta",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24928016",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dominant inheritance of osteogenesis imperfecta (OI) is caused by mutations in COL1A1 or COL1A2, the genes that encode type I collagen,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21667357",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) is a heterogeneous group of inherited disorders of bone formation, resulting in low bone mass and an increased propensity to fracture. It exhibits a broad spectrum of clinical severity, ranging from multiple fractures in utero and perinatal death, to normal adult stature and low fracture incidence. Extra-skeletal features of OI include blue sclera, hearing loss, skin hyperlaxity, joint hyperextensibility, and dentinogenesis imperfecta. The pro\u03b11(I) and pro\u03b12(I) chains of collagen 1 are encoded by the COL1A1 and COL1A2 genes, respectively; quantitative or qualitative defects in type I collagen synthesis usually manifest as types of OI or some sub-types of EDS. The majority of patients (about 90%) with a clinical diagnosis of OI have a mutation in the COL1A1 or COL1A2",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21567925",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) type I is characterized by bone fragility without significant deformity, osteopenia, normal stature, blue sclerae, and autosomal dominant inheritance. Dermal fibroblasts from most affected individuals produce about half the expected amount of type I collagen, suggesting that the OI type I phenotype results from a variety of mutations which alter the apparent expression of either COL1A1 or COL1A2, the genes encoding the chains of type I collagen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8456806",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Autosomal dominant osteogenesis imperfecta is caused by mutations in the COL1A2 and COL1A1 genes of type I collagen. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2886666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta is caused by dominant autosomal mutations in the type I collagen coding genes (COL1A1 and COL1A2) in about 85% of individuals, affecting collagen quantity or structure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28820180",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) is a heterogeneous group of disorders of connective tissue, mainly caused by mutations in the collagen type I genes (COL1A1 and COL1A2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27510842",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Autosomal dominant osteogenesis imperfecta (OI) is caused by mutations in the genes (COL1A1 or COL1A2) encoding the chains of type I collagen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18566967",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In approximately 90% of individuals with osteogenesis imperfecta, mutations in either of the genes encoding the pro-alpha1 or pro-alpha2 chains of type I collagen (COL1A1 or COL1A2) can be identified.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19533842",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Autosomal dominant OI is caused by mutations in the genes (COL1A1 or COL1A2) encoding the chains of type I collagen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20839288",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ext-generation sequencing technology was used to screen a panel of known OI genes.RESULTS: In 41 probands, we identified 28 different disease-causing variants of 9 different known OI genes. Eleven of the variants are novel. Ten of the 28 variants are located in COL1A1, five in COL1A2, three in BMP1, three in FKBP10, two in TMEM38B, two in P3H1, and one each in CRTAP, SERPINF1, and SERPINH1. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29150909",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous disorder associated with bone fragility and susceptibility to fractures after minimal trauma. OI type V has an autosomal-dominant pattern of inheritance and is not caused by mutations in the type I collagen genes COL1A1 and COL1A2. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22863195",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2992938",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2037280",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Osteogenesis imperfecta (OI), commonly known as \"brittle bone disease\", is a dominant autosomal disorder characterized by bone fragility and abnormalities of connective tissue. Biochemical and molecular genetic studies have shown that the vast majority of affected individuals have mutations in either the COL1A1 or COL1A2 genes that encode the chains of type I procollagen. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12362985",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteogenesis imperfecta is normally caused by an autosomal dominant mutation in the type I collagen genes COL1A1 and COL1A2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21341209",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.biosemantics.org/jochem#4249099",
    "http://www.disease-ontology.org/api/metadata/DOID:0110341",
    "http://www.disease-ontology.org/api/metadata/DOID:0110340",
    "http://www.disease-ontology.org/api/metadata/DOID:0110343",
    "http://www.disease-ontology.org/api/metadata/DOID:0110337",
    "http://www.disease-ontology.org/api/metadata/DOID:0110338",
    "http://www.disease-ontology.org/api/metadata/DOID:0110342",
    "http://www.disease-ontology.org/api/metadata/DOID:0110336",
    "http://www.disease-ontology.org/api/metadata/DOID:0110335",
    "https://meshb.nlm.nih.gov/record/ui?ui=D010013",
    "http://www.disease-ontology.org/api/metadata/DOID:0110334",
    "http://www.disease-ontology.org/api/metadata/DOID:12347",
    "https://meshb.nlm.nih.gov/record/ui?ui=D005799"
  ],
  "exact_answer": "Yes"
}